Talis Biomedical Corp - Delisted Pink Sheet
Talis Biomedical Corp cannot be verified against its exchange. Apparently, Talis Biomedical is not available for investing at the moment. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Note that a delisted financial instrument is a security that has been removed from its exchange and is no longer traded publicly. This can occur for various reasons, such as bankruptcy, merger, or failure to meet exchange listing requirements. Delisted instruments can still trade in the over-the-counter (OTC) market, but they are typically less liquid and carry higher risk compared to assets listed on a major exchange. Check all delisted instruments accross multiple markets.
Talis Biomedical Corp Risk Profiles
| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (1.76) | |||
| Total Risk Alpha | (3.55) | |||
| Treynor Ratio | 1.63 |
Try Other Suggestions
Talis Biomedical Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Talis Biomedical pink sheet to make a market-neutral strategy. Peer analysis of Talis Biomedical could also be used in its relative valuation, which is a method of valuing Talis Biomedical by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Talis Biomedical Corporate Management
| Roger Moody | Chief Officer | Profile | |
| Gillian Green | Company Secretary | Profile | |
| Margaret MS | Controller | Profile | |
| Rustem Ismagilov | CoFounder Director | Profile | |
| Rebecca Markovich | Interim Officer | Profile | |
| Jill Green | Senior Legal | Profile |
Still Interested in Talis Biomedical Corp?
Investing in delisted pink sheets can be risky, as the pink sheet is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in Talis Pink Sheet
If you are still planning to invest in Talis Biomedical Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Talis Biomedical's history and understand the potential risks before investing.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |